Back to the main directory
Event / Equity
- Espresso | Anima | Buy | July net inflows, at last by Kepler Cheuvreux
- Espresso | Fred Olsen Energy | Not Rated | Awaiting final outcome of refinancing discussions by Kepler Cheuvreux
- Espresso | Pirelli | Hold | Solid Q2 earnings on higher HV volumes and sustained price/mix by Kepler Cheuvreux
- Espresso | Schaeffler | Buy | Our level of confidence is rising by Kepler Cheuvreux
- Espresso | Banca Farmafactoring | Buy | Good Q2, in line, more visibility on embedded growth, upgrade to Buy by Kepler Cheuvreux
- Espresso | Ahold Delhaize | Buy | Q2 results in line with expectations by Kepler Cheuvreux
- Espresso | Heidelberger Druck | Buy | Positive feedback from conference call by Kepler Cheuvreux
- Espresso | SpareBank 1 Nord-Norge | Hold | Improving credit quality and higher costs by Kepler Cheuvreux
- Espresso | Corbion | Buy | Accelerating sales growth, at last by Kepler Cheuvreux
- Espresso | Fraport | Buy | Rather weak set of results by Kepler Cheuvreux
- Espresso | Page Group | Hold | Solid H1 earnings growth by Kepler Cheuvreux
- Espresso | Munich Re | Hold | Operating profit miss of -10% driven by weak P&C Re by Kepler Cheuvreux
- Espresso | Ageas | Hold | Q2 in line excluding one-offs, strong SII ratio by Kepler Cheuvreux
- Espresso | Lundbeck | Reduce | Cipralex drives top-line beat, key growth drivers have a lacklustre Q2 by Kepler Cheuvreux
- Espresso | SpareBank 1 SMN | Hold | Higher losses and costs, but strong net interest income by Kepler Cheuvreux
- Espresso | Jungheinrich | Hold | Solid Q2 pre-released, sales and orders guidance now at upper end by Kepler Cheuvreux
- Espresso | Ahold Delhaize | Hold | Fairly valued by Kepler Cheuvreux
- Espresso | Bpost | Hold | Good and bad by Kepler Cheuvreux
- Espresso | Fraport | Buy | Reassuring conference call by Kepler Cheuvreux
- Espresso | Zurich Insurance | Hold | H1 results in line on underlying basis by Kepler Cheuvreux
- Espresso | Deutsche Telekom | Buy | Broadly in line by Kepler Cheuvreux
- Espresso | Jenoptik | Hold | Q2: results in line, orders in O&LS soften by Kepler Cheuvreux
- Espresso | Lanxess | Buy | Arlanxeo deal to come earlier by Kepler Cheuvreux
- Espresso | KBC | Reduce | Disappointing Q2 by Kepler Cheuvreux
- Espresso | Valiant | Reduce | Net income in line, though lending growth for FY to be below target by Kepler Cheuvreux